Reduced Quality of Life

Slides:



Advertisements
Similar presentations
End of life research in COPD
Advertisements

GOLD Clasification Antonio Anzueto MD Professor Medicine University of Texas.
Introduction Chronic obstructive pulmonary disease (COPD) is related to increased fatigue, decreased health status, and increased mortality. Studies with.
End stage Lung Disease: What is it and what are some treatment options? NC Cardiopulmonary Rehabilitation Association Meeting March 14, 2014;
6 th Meeting of the Task Force on Health Expectancies 2 nd June 2008 Carol Jagger and Clare Gillies, University of Leicester Validating the GALI Question.
GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.
COPD Diagnosis & Management Anil Ramineni Specialist Respiratory Physiotherapist Community Respiratory Team.
Chronic Obstructive Pulmonary Disease Austin Paul K.
Picking up the Clues Bert the breathless patient….. March 2015 GL/XBR/0315/0356.
Management of stable chronic obstructive pulmonary disease (2) Seminar Training Primary Care Asthma + COPD D.Anan Esmail.
Development of disability in chronic obstructive pulmonary disease : beyond lung function MarkDEisner, CarlosIribarren, PaulDBlanc, EdwardHYelin, LynnAckerson,
The Impact of Disability on Depression Among Individuals With COPD Patricia P. Katz, PhD ; Laura J. Julian, PhD ; Theodore A. Omachi, MD, MBA ; Steven.
A development study of pulmonary rehabilitation for patients with chronic lung disease in Uganda. Jones, R. Kirenga, B. Pooler, J. Katagira, W. Kasiita,
GOLD 2017 major revision: Summary of key changes
Wales Primary Care COPD Audit
Contribution of Physical Education to Physical Activity of Children
External multicentric validation of a COPD detection questionnaire.
Publications Analysis of nocturnal actigraphic sleep measures in patients with COPD and their association with daytime physical activity. Spina G et.
Thank you for viewing this presentation.
Why anxiety associates with non-completion of pulmonary rehabilitation program in patients with COPD? Dr Abebaw Mengistu Yohannes Associate Professor.
A new preoperative Severity Scoring System For Acute Cholecystitis
The Minimal Important Difference for St
An Exploration of the Relationship Between Physical Activity, Mortality and Time to First Admission in Subjects Admitted into.
Appropriateness of the metabolic equivalent (MET) as an estimate of
Department of Respiratory Medicine
East Tennessee State University
A simple tool to promote Physical Activity in patients with COPD
S Lungaro-Mifsud, S Montefort
Dr. Kevin Gruffydd-Jones Box Surgery, Wiltshire, England
Peak oxygen uptake and prevalence of cardiovascular disease risk factors in breast cancer survivors Lahart1, I.M., Metsios1, G.S., Nevill1, A.M., Kitas1,2,
Clare Lewis1 Zena Moore 2 Tom O’Connor3 Declan Patton4 Linda E Nugent5
COPD Report 5 Coles Lane, Oakington, Cambridge, CB24 3BA.
Lynn Josephs, David Culliford, Matthew Johnson, Mike Thomas
Classification of chronic obstructive pulmonary disease (COPD) severity according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD):
Correlation Between Five Exercise Tests to the COPD Assessment Test (CAT) in Stable Chronic Obstructive Pulmonary Disease (COPD)
Table1. Average Activity Counts
Frailty and its association with conventional risk factors for CAD among elderly patients with acute coronary syndrome.
The authors have no competing interests to declare.
Blood eosinophil count and exacerbation risk in patients with COPD
Change in physical activity level following COPD exacerbation
PHQ2 Screening Negative PHQ2 Screening Positive
Assessing COPD in Primary Care
Treatment Strategies in Mild to Moderate COPD
Are cardiac rehabilitation patients meeting the physical activity guidelines 12-months after their event? a longitudinal study Dr Nicole Freene Ms Margaret.
Examining the Effectivenesses of the IMPACT Program
Comparison of the characteristics at first enrolment for United Network for Organ Sharing (UNOS) patients (n=8315) and virtual patients (n=2 048 784).
Patients with exacerbations of chronic obstructive pulmonary disease admitted to hospital according to the day of the week (A), and presenting to the emergency.
Influence of do-not-resuscitate (DNR) order specification on overall survival in chronic obstructive pulmonary disease (COPD) patients (log rank test p
Distribution of lower extremity artery disease (LEAD) Fontaine stages over the combined chronic obstructive pulmonary disease (COPD) Global Initiative.
Serum levels of angiopoietin-like protein 4 (ANGPTL4) according to patients with chronic obstructive pulmonary disease and controls without any lung disease.
Body mass index (BMI) among subjects with normal spirometry, chronic obstructive pulmonary disease (COPD) and restrictive spirometry. Body mass index (BMI)
Level of physical activity by Global Initiative for Obstructive Lung Disease (GOLD) stage, BODE (body mass index, FEV1 for airflow obstruction, dyspnoea,
Occurrence of morning symptoms
A.M. CLARKE-CORNWELL1, P.A. COOK1 and M.H.GRANAT1
Diagnosi della BPCO 1.
Management of Chronic Stable COPD
Effects of chronic obstructive pulmonary disease (COPD) severity on different parameters of ventilatory inefficiency during incremental cardiopulmonary.
In the name of Almighty, Eternal, Just And Merciful GOD
Morbidity and mortality benefits with statin use in observational studies on a logarithmic scale. Morbidity and mortality benefits with statin use in observational.
Scatter plot of body mass index (BMI) versus forced expiratory volume in the first second (FEV1), and linear correlation lines for normal spirometry and.
Screening test accuracy of the final risk score at a threshold of ≥2
Distribution of patients in the first- or second-year follow-up according to the number of acute exacerbations of chronic obstructive pulmonary disease.
Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification based on symptom and risk evaluation. a) GOLD model of symptom/risk evaluation.
D94- COPD: EPIDEMIOLOGY AND THERAPY
Distribution of NEWS in the community by service
Chronic obstructive pulmonary disease (COPD) prevalence (postbronchodilator FEV1/FVC (forced expiratory volume in 1 s/forced vital capacity)
Khai Hoan Tram, Jane O’Halloran, Rachel Presti, Jeffrey Atkinson
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) ABCD scheme for classifying patients with COPD with separate appraisal of air-flow limitation.
Frequency distribution histograms of the Exacerbations of Chronic Pulmonary Disease Tool (EXACT) total, the COPD Assessment Test (CAT), the St George’s.
Association of objective and self-reported PA measurements and VAT mass. Association of objective and self-reported PA measurements and VAT mass. Linear.
Presentation transcript:

Reduced Quality of Life Self-reported symptom severity and physical activity, sedentary time and physical function in COPD patients with mild-moderate airflow obstruction Mark Orme 1; Dale Esliger 1; Sally Singh 1, 2; Michael Steiner 1, 2; Mike Morgan 2; Andrew Kingsnorth 1; Lauren Sherar 1 1 SSEHS, NCSEM, Loughborough University, UK 2 University Hospitals of Leicester, UK INTRODUCTION METHODS RESULTS Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally (1). Large heterogeneity in COPD patient symptoms exists, including dyspnea and exacerbations (2). The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011 multidimensional system for COPD assessment (3) (Fig 1) stratifies patients based on symptom severity using two methods (Figs 2 and 3). COPD patients are less physically active compared with healthy counterparts (4). Leading a less active and sedentary lifestyle, even in the early stages of COPD progression, may have a detrimental effect on symptoms and quality of life (5) (Fig 4) Study Sample Group A and B Comparisons Analysis of covariance (age, gender, wear time) revealed that patients in CAT-A achieved higher ISWT distances (Fig 6 A) and were less sedentary compared with CAT-B patients (Fig 6 B). ISWT distance and time sedentary did not differ significantly between mMRC groups (Table 3). Physical activity did not differ between A and B groups, for both symptom assessment tools. A cross-section of primary care recruited COPD patients from Leicestershire, UK as part of the Physical Activity and Respiratory Health (PhARaoH) Study. The sample comprised 96 mild-moderate COPD patients (66.3±6.8 years, 62.5% male, 66.7% retired) Patient Stratification Data Collection Fig 5 – Distribution of patients across groups A (low symptoms; blue) and B (high symptoms; red), by CAT and mMRC Table 1 – List of measures Outcome Measure(s) Symptoms CAT scores mMRC score Exacerbations history Physical Activity and Sedentary Behaviour Wrist-worn accelerometry ActiGraph wGT3X-BT 7 days of wear Physical Function Incremental Shuttle Walk Test (ISWT) Grip strength (kg) Leg strength (kg) Lung Function Forced spirometry Body Composition Body mass index (kg/m2) Fig 6 – Adjusted means (age, gender, wear time) (SE) for physical function (Panel A) and sedentary behaviour (Panel B) { * ** A B CAT-A and CAT-B mMRC-A and mMRC-B C A D B CAT Score 0 - 9 10 - 40 Respiratory GOLD 1 - 2 3 - 4 mMRC Score 0 - 1 2 - 4 Fig 1 – GOLD groups Fig 2 – CAT form Individual Symptom Assessment Linear regressions (Table 4) showed that total CAT was significantly related with ISWT distance and time sedentary. The mMRC score was associated with ISWT distance, time sedentary and counts per minute. Breathless, limited activities, confidence leaving the home and energy scores were significantly associated with physical behaviours and/or ISWT distance. Breathless score was the only symptom indicator to be significantly related to all outcomes. Group B had a higher number of previous exacerbations compared with group A. This difference was greatest between mMRC groups (Table 2). Table 2 - Patient characteristics by CAT and mMRC groups A and B, median (IQR)   CAT-A (n=33) CAT-B (n=63) mMRC-A (n=79) mMRC-B (n=17) Age (years) 69.0 (7.5) 67.0 (10.0) 69.0 (9.0) 67.0 (13.0) Gender (% male) 23 (69.7) 37 (58.7) 49 (62.0) 11 (64.7) FEV1/FVC 56.0 (11.0) 52.5 (16.0) 55.0 (14.0) 44.0 (15.0) FEV1%pred 78.0 (23.5) 70.5 (22.3) 76.0 (23.8) 63.0 (20.0) Body Mass Index (kg/m2) 27.4 (4.6) 27.5 (6.6) 28.0 (5.3) 28.6 (10.0) Exacerbations 0 (1) 0 (3)* 3 (4)** Grip Strength (kg) 38.0 (16.5) 33.3 (19.6) 35.5 (19.0) 36.0 (23.3) Leg Strength (kg) 36.0 (18.5) 34.0 (20.0) 32.0 (21.0) 38.0 (14.5) Table 4 – Associations of individual symptoms with physical behaviours and function, controlling for age, gender and wear time   ISWT Distance Counts per minute PA ≥4000 Time Sedentary β R2 Total CAT Score (0-40) -6.2** 0.22 2.0* 0.33 Breathless (0-5) -29.0** 0.21 -61.4** 0.09 -3.6** 0.20 15.9*** 0.40 Limited Activities (0-5) -41.5*** 0.27 -52.4* 0.05  -3.8**  0.19 Leave the Home (0-5) -33.1* Energy (0-5) -51.8*** 0.30 12.8* 0.34 mMRC Score (0-4) -99.2** -111.9** 0.08 33.1* Exacerbations (0-8) -29.3** 0.24 -2.5* 0.17 Fig 3 – mMRC form Symptoms Inactivity Reduced Quality of Life Deconditioning Sedentariness Anxiety Depression Fig 4 – Conceptual model: activity and symptoms *p<0.05; **p<0.01 Table 3 – Adjusted means (age, gender, wear time) (SE) for physical behaviour and function by CAT and mMRC groups A and B   CAT-A CAT-B mMRC-A mMRC-B ISWT Distance (m) 455 (25) 364 (19)** 409 (17) 341 (39) Counts Per Minute 1203 (53) 1076 (38) 1129 (35) 1078 (79) PA >2000cpm (mins) 174 (10) 149 (7) 158 (7) 152 (15) PA >5000cpm (mins) 9 (1) 6 (1) 7 (1) 7 (2) Time Sedentary (mins) 514 (11) 541 (8)* 531 (7) 538 (16) Wear Time (mins) 697 (9) 710 (7) 703 (6) 714 (13) *p<0.05; **p<0.01; ***p<0.001 AIMS CONCLUSIONS To compare physical activity, sedentary behaviour and physical function between GOLD 2011 symptom groups A and B. Choice of symptom assessment (CAT or mMRC) impacts the characteristics of resulting groups in relation to physical function and behaviours. *p<0.05; **p<0.01 To investigate the associations of physical activity, sedentary behaviour and physical function with individual symptoms in primary care COPD patients. References Symptoms are better related to physical function than physical activity. Individual CAT scores such as energy provide additional insight into the relationship between symptoms and both physical function and behaviours. (1) Soriano et al. (2012) Med Clin North Am 96: 671-80; (2) Agusti et al. (2010) Respir Res 11: 122; (3) Global Initiative for Chronic Obstructive Lung Disease (2014); (4) Tudor-Locke et al. (2009) Prev Med 49: 3-11; (5) Aguilaniu & Roche (2014) Prim Care Respir Med 24: 14014 www.paphrg.org m.w.orme@lboro.ac.uk @paphrg